Virginia Retirement Systems’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-41,665
Closed -$1.68M – 1305
2026
Q1
$1.68M Buy
41,665
+17,300
+71% +$373K 0.01% 469
2025
Q4
$612K Sell
24,365
-1,100
-4% -$25.8K ﹤0.01% 711
2025
Q3
$576K Sell
25,465
-2,200
-8% -$51.3K ﹤0.01% 720
2025
Q2
$479K Buy
27,665
+3,000
+12% +$55.5K ﹤0.01% 759
2025
Q1
$539K Buy
+24,665
New +$681K ﹤0.01% 729
2023
Q3
$373K Buy
9,800
+3,000
+44% +$132K ﹤0.01% 771
2023
Q2
$619K Sell
6,800
-4,000
-37% -$345K 0.01% 670
2023
Q1
$712K Sell
10,800
-4,200
-28% -$242K 0.01% 639
2022
Q4
$776K Sell
15,000
-1,000
-6% -$53K 0.01% 687
2022
Q3
$1.09M Buy
+16,000
New +$947K 0.01% 548
2022
Q1
$305K Buy
6,000
+400
+7% +$17.7K ﹤0.01% 970
2021
Q4
$265K Buy
+5,600
New +$220K ﹤0.01% 1007

Other funds holding APLS

Virginia Retirement Systems's APLS Position: Q2 2026 in Review

Virginia Retirement Systems sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 41,665 shares — an estimated $1.68M sold.

Virginia Retirement Systems first reported a position in APLS in Q4 2021 and held it in 12 quarters. The position peaked at $1.68M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Virginia Retirement Systems reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 41,665 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.68M.
  • Virginia Retirement Systems first reported a position in Apellis Pharmaceuticals in Q4 2021 and held it in 12 quarters.
  • Virginia Retirement Systems's Apellis Pharmaceuticals position peaked at $1.68M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.